Amalia Raptopoulou

The programmed death 1/programmed death ligand 1 inhibitory pathway is up‐regulated in rheumatoid synovium and regulates peripheral T cell responses in human and murine arthritis

Amalia Raptopoulou, George Βertsias, Dimitrios Makrygiannakis et al. · Arthritis & Rheumatism · 2010 · 202 citations

Life Sciences, Immunology, Pathobiology +17

Expansion of toll‐like receptor 9–expressing B cells in active systemic lupus erythematosus: Implications for the induction and maintenance of the autoimmune process

Eva D. Papadimitraki, Christianna Choulaki, Eleni Koutala et al. · Arthritis & Rheumatism · 2006 · 185 citations

Life Sciences, Immunology, Pathobiology +17

Anti-tumor necrosis factor therapy improves insulin resistance, beta cell function and insulin signaling in active rheumatoid arthritis patients with high insulin resistance

Ilias Stagakis, George Βertsias, Stylianos Karvounaris et al. · Arthritis Research & Therapy · 2012 · 173 citations · Full text

Medicine, Immunology, Pharmacology +17

Rituximab therapy reduces activated B cells in both the peripheral blood and bone marrow of patients with rheumatoid arthritis: depletion of memory B cells correlates with clinical response

Magda Nakou, Georgios Katsikas, Prodromos Sidiropoulos et al. · Arthritis Research & Therapy · 2009 · 133 citations · Full text

Life Sciences, Immunology, Internal Medicine +17

Genetic, immunologic, and immunohistochemical analysis of the programmed death 1/programmed death ligand 1 pathway in human systemic lupus erythematosus

George Βertsias, Magda Nakou, Christianna Choulaki et al. · Arthritis & Rheumatism · 2008 · 109 citations

Life Sciences, Immunology, Molecular Genetics +17